Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-022770
Filing Date
2021-06-29
Accepted
2021-06-29 21:21:10
Documents
2
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1504
2 EXHIBIT 24 brhc10026364_ex24.htm EX-24 10187
  Complete submission text file 0001140361-21-022770.txt   13136
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Dubensky Thomas W. (Reporting) CIK: 0001635590 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 211060166